A 26-year-old woman with a 3-year history of systemic lupus erythematosus (SLE) presents to the clinic with 2 weeks of worsening bilateral lower extremity edema and newly frothy urine. Her current medications include hydroxychloroquine and low-dose prednisone. Vital signs show a blood pressure of 152/94 mm Hg. Physical examination reveals 2+ pitting edema up to the mid-calves. You suspect new-onset lupus nephritis. Arrange the following steps in the standard sequential order for the diagnostic evaluation and subsequent therapeutic management of this patient.
- 1Noninvasive laboratory evaluation with a spot urine protein-to-creatinine ratio and serologic markers (e.g., anti-dsDNA, complement levels)
- 2Percutaneous ultrasound-guided renal biopsy for histopathologic classification
- 3Induction immunosuppressive therapy with high-dose glucocorticoids and a potent agent such as mycophenolate mofetil
- 4Transition to maintenance immunosuppressive therapy with lower-dose glucocorticoids and a long-term steroid-sparing agent
Answer
The correct sequence is: Noninvasive laboratory evaluation, followed by Percutaneous renal biopsy, then Induction immunosuppressive therapy, and finally Transition to maintenance immunosuppressive therapy.
The standard of care for new-onset lupus nephritis begins with noninvasive confirmation of proteinuria and serologic activity. Once confirmed, a renal biopsy is strictly required to classify the disease (e.g., distinguishing between proliferative and pure membranous nephritis), as this classification dictates treatment. For proliferative classes, treatment is divided into a short, aggressive induction phase to halt renal inflammation, followed by a prolonged, less toxic maintenance phase to prevent relapse.
Step-by-Step Solution
Key Concept
Stepwise diagnostic and therapeutic management of Lupus Nephritis